MEDIUMBuilt-inGeographic
United States beverage sales
“10-K Item 1: 'our beverage alcohol products were predominantly sold in the United States'”
TLRY · Concentration risk · 10-K extracted
Tilray Brands (TLRY) concentration risks
Updated
The most significant concentration Tilray Brands discloses is United States beverage sales, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Tilray Brands’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 2 disclosed concentrations
HIGH0
MEDIUM2
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
MEDIUMBuilt-inRegulatory
Canadian provinces and territories cannabis distribution
“10-K Item 1A: 'each province and territory of Canada has the ability to separately regulate the distribution of cannabis within such province or territory'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-10-18Tilray's disclosed concentrations are geographic and regulatory, and both are structural. In the beverage business, the filing states that its beverage alcohol products were predominantly sold in the United States, a medium-share exposure that ties that part of the company to a single national market's demand, distribution and regulatory conditions. On the cannabis side, each province and territory of Canada has the ability to separately regulate distribution of cannabis within its own jurisdiction. This is also a medium-share exposure and structural in character: it is a feature of how the Canadian market is organized, not a dependency on one named customer. It does, however, mean that the company faces a patchwork of rules rather than one uniform framework, which can complicate planning and execution. Taken together, the two exposures are not offsetting. They sit in different product lines and different countries, so they diversify one another to a degree, yet each is a standing condition of its own market. The filing gives no percentages, so neither can be sized beyond its band. The net picture is of moderate, well-disclosed structural exposures rather than a sharp single-counterparty risk.
For the engine’s reasoning on TLRY’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Drug Manufacturers - Specialty & Generic
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ANIP | ANI Pharmaceuticals, Inc. | 2 | 1 | 0 | 3 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 2 | 0 | 0 | 2 |
| AMPH | Amphastar Pharmaceuticals, Inc. | 1 | 2 | 1 | 4 |
| AMRX | Amneal Pharmaceuticals, Inc. | 1 | 1 | 0 | 2 |
| TLRY● | Tilray Brands, Inc. | 0 | 2 | 0 | 2 |
| ALKS | Alkermes plc | 0 | 1 | 1 | 2 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.